Innovation Hub
The latest breakthroughs, technologies, and resources across every stage in the drug development lifecycle.
Button Text






.avif)







Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Blog
The Case for Early Developability Assessment in Antibody Discovery
December 9, 2025
Sponsored by:
Sponsor
Read blog
Antibodies
Protein Sciences
Cell Culture & Characterization
In Vitro Assays
Biointron

Blog
What the New U.S.-UK Pharmaceuticals Deal Really Means for Pricing, Access, and Global Market Dynamics
December 5, 2025
Read blog
Market Access
No items found.

Blog
AI's Quiet Revolution in the Pharma Supply Chain with Chris Petersen, Scientist.com
December 5, 2025
Read blog
Chemistry, Manufacturing & Controls
No items found.

Blog
Advancing Sarcopenia Research: CUHK Lab Unveils Early NMJ Deficits in Aging with Aurora Scientific's 1200A
December 1, 2025
Sponsored by:
Sponsor
Read blog
Disease Models
Aurora Scientific, Inc.

Blog
Reflect on 20 Years of Cancer Research with MIRROR Biospecimens
November 18, 2025
Sponsored by:
Sponsor
Read blog
Biomarkers
Cell Culture & Characterization
Protein Sciences
DNA & RNA
Precision for Medicine

Blog
Faster Insights or Faster Fail? How to Avoid the Misuse of Real-World Data when Using AI
November 12, 2025
Sponsored by:
Sponsor
Read blog
Real-World Data (RWD)
Panalgo, LLC

Blog
Building Bridges in Muscle Research: The Story Behind AMB's Innovative Approach and Partnership with Aurora Scientific
November 5, 2025
Sponsored by:
Sponsor
Read blog
No items found.
Aurora Scientific, Inc.
.avif)
Blog
Using Real-World Data to Understand the Impact of IRA Policy on Patient Outcomes and Health Equity
October 22, 2025
Sponsored by:
Sponsor
Read blog
Real-World Data (RWD)
Panalgo, LLC

Blog
When the Evidence Fails the Drug: Is the Role of Study Design Being Overlooked During Discovery?
October 16, 2025
Sponsored by:
Sponsor
Read blog
Health Economics & Outcomes Research (HEOR)
Adigens Health

Blog
Bringing Clarity and Efficiency to Early Drug Screening: How Chemical Protein Stability Assays (CPSA) Help Drive Decisions at the Hit/Lead Discovery Stage
October 15, 2025
Sponsored by:
Sponsor
Read blog
Protein Sciences
Discovery Chemistry
In Vitro Assays
Medicines Discovery Catapult
Disease Models
Instrumentation & Products
Satish R. Raj
Nasia Sheikh
Finapres Medical Systems
No items found.
Chemical & Compound Analysis
Björn Heitmann
Barbara Czarniecki
Bruker Corporation
No items found.
Disease Models
Jonas Treebak
Alexander Bartelt
Sable Systems International Inc.
No items found.
Health Economics & Outcomes Research (HEOR)
Real-World Evidence (RWE)
Michael Broder
Jesse Ortendahl
PHAR
HealthEconomics.com
Disease Models
Sue Bodine
Aurora Scientific, Inc.
American Physiological Society
Alliance for Aging Research
Disease Models
Paul Marvar
Benjamin Turley
Data Sciences International
Harvard Bioscience, Inc.
No items found.
Market Access
Medical Communications
Health Economics & Outcomes Research (HEOR)
Steven Fountain
Sonya Snedecor
Sajjad Raza
PRECISIONheor
OPEN Health
PRMA Consulting
Scientist.com
Market Access
Medical Communications
Sajjad Raza
Steven Fountain
Sonya Snedecor
OPEN Health
PRECISIONheor
PRMA Consulting
Scientist.com
Disease Models
Stefano Gaburro
Brun Ulfhake
Tecniplast S.p.A.
American Physiological Society
Alliance for Aging Research
Disease Models
Aileen King
Data Sciences International
Harvard Bioscience, Inc.
No items found.
Cell Culture & Characterization
Pharmacology
Toxicology
Daniel Merriman
Femi Egbebi
Krzysztof Inglot
Thermo Fisher Scientific
No items found.
Pharmacology
Jonathan Nakashima
Grace Walton
Certis Oncology Solutions, Inc.
Hera BioLabs
Scientist.com
Disease Models
Rohan Jagirdar
Data Sciences International
Harvard Bioscience, Inc.
No items found.

Podcast
From Data Access to Evidence Usability: Connecting Payer Policy, Real-World Data, and Clinical Context to Close the Evidence Gap
July 13, 2026
Read podcast
Health Economics & Outcomes Research (HEOR)
Market Access
Medical Communications
Real-World Data (RWD)
Real-World Evidence (RWE)
Real-World Evidence (RWE)
Clinical Trials
Real-World Data (RWD)
Real-World Evidence (RWE)

Podcast
Integrated Evidence Delivery: Why HEOR belongs at the heart of the Modern CRO
February 23, 2026
Read podcast
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)

Podcast
tHEORetically Speaking: Rethinking Decentralization in Direct-to-Patient Studies
October 6, 2025
Read podcast
Health Economics & Outcomes Research (HEOR)
Clinical Trials
Health Economics & Outcomes Research (HEOR)
Real-World Data (RWD)
Instrumentation & Products
Trial Insights
Real-World Evidence (RWE)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Market Access
Medical Communications
Real-World Evidence (RWE)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Health Economics & Outcomes Research (HEOR)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Market Access
No items found.

Whitepaper
Insights from Spatial Biology in Drug Discovery at IRBM: The Impact of Cellular Ecosystems
July 28, 2026
Sponsored by:
Sponsor
Access now
Bioimaging
Biomarkers
DNA & RNA
Protein Sciences
Disease Models
IRBM

Whitepaper
Direct to Biology: An Approach to Streamline the DMTA Cycle in PROTAC Discovery
July 7, 2026
Sponsored by:
Sponsor
Access now
Protein Sciences
Pharmacology
In Vitro Assays
DMPK
Concept Life Sciences






















.avif)






